Saudi FDA suspends imports from UAE's Julphar on violations

16/09/2018 Argaam

 

Saudi Food and Drug Authority (SFDA) has temporarily suspended imports from Gulf Pharmaceutical Industries (Julphar) due to non-compliance with manufacturing regulations, according to the FDA Twitter account.

 

This decision came after several violations were detected in an FDA inspection. 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.